Skip to content

Clinical Efficacy of Acupuncture on Rheumatoid Arthritis and Associated Mechanisms: A Systemic Review

Chou et al. · Evidence-Based Complementary and Alternative Medicine · 2018

📚Systematic Review👥n=43 studies🌟High impact

Evidence Level

MODERATE
75/ 100
Quality
4/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

To investigate the clinical efficacy of acupuncture in rheumatoid arthritis and elucidate the proposed mechanisms

👥

WHO

43 studies analyzed (1974-2018) including patients with rheumatoid arthritis and animal models

⏱️

DURATION

Studies from 1974 to 2018 with durations ranging from 5 days to 3 months

📍

POINTS

ST-36 (most-used), followed by GB-34, LI-4, BL-60, GB-39

🔬 Study Design

1500participants
randomization

Randomized clinical trials

n=33

Acupuncture compared with controls

Animal studies

n=10

Models of induced rheumatoid arthritis

⏱️ Duration: Variable: 5 days to 3 months

📊 Results in numbers

79.2% to 95%

Total effectiveness rate

0

Double-blind studies

0

Adverse events reported

Most studies

Significant symptom improvement

Percentage highlights

79.2% to 95%
Total effectiveness rate

📊 Outcome Comparison

Effectiveness rate

Acupuncture + moxibustion
88.5
Acupuncture + herbal medicine
94.3
Acupuncture alone
79.2
💬 What does this mean for you?

This review showed that acupuncture may be a safe and effective treatment for rheumatoid arthritis, improving symptoms such as pain and inflammation. Acupuncture may work through anti-inflammatory effects and immune-system regulation, making it a valid complementary option for patients with rheumatoid arthritis.

📝

Article summary

Plain-language narrative summary

This comprehensive systematic review examined 43 studies conducted between 1974 and 2018 to evaluate the clinical efficacy of acupuncture in the treatment of rheumatoid arthritis (RA) and its proposed mechanisms of action. Rheumatoid arthritis is a chronic autoimmune inflammatory disease that affects 0.2-1% of the population, causing persistent synovitis, joint destruction, and significant morbidity. The authors performed a comprehensive search across multiple databases including PubMed, EMBASE, Cochrane, and CNKI, analyzing both human and animal-model studies. The methodology included detailed analysis of study design, subject characteristics, interventions, acupuncture points used, assessment parameters, and proposed mechanisms.

Of the 43 studies analyzed, 33 were randomized clinical trials, 4 of them double-blind. The studies included both human patients with RA and animal models, primarily rats and rabbits with adjuvant-induced RA. Sample sizes varied significantly, with some studies including more than 100 participants. The most frequently used acupuncture point was ST-36 (Zusanli), followed by GB-34, LI-4, BL-60, and GB-39.

Protocols ranged from single points to more than 10 points, with treatment durations of 5 days to 3 months. Interventions included traditional acupuncture, electroacupuncture, laser acupuncture, moxibustion, and herb-point stimulation. The results consistently showed that acupuncture, whether alone or combined with other modalities, was beneficial for the clinical conditions of RA. Effectiveness rates ranged from 79.2% to 95%, depending on the modality used.

Notably, no adverse events were reported in any of the studies. Acupuncture demonstrated significant improvements in symptoms such as pain, morning stiffness, tender and swollen joint counts, and laboratory parameters including ESR, CRP, and rheumatoid factor. Several mechanisms were proposed to explain the therapeutic effects. The anti-inflammatory effect was the most frequently suggested mechanism, with studies demonstrating reduction of inflammatory cytokines such as TNF-α, IL-1, IL-6, and modulation of nuclear factor kappa B (NF-κB).

Regulation of immune function was another important mechanism, with studies showing alterations in immunoglobulins and immune cell function. Antioxidant effects were also proposed, including increased activity of superoxide dismutase and catalase. Some studies suggested central analgesic effects through increased endorphins in cerebrospinal fluid. The clinical implications are significant, suggesting that acupuncture may be a valuable complementary treatment modality for patients with RA, especially considering its safety and the absence of reported adverse events.

The review also highlighted the importance of Traditional Chinese Medicine theory in point selection and treatment protocols. However, the authors identified several important limitations, including inconsistencies in reported clinical efficacy and a paucity of well-designed double-blind studies. Standardization of treatment protocols remains a challenge, particularly regarding the application of TCM theory in contemporary research.

Strengths

  • 1Comprehensive review covering 44 years of research
  • 2Detailed analysis of 43 studies including humans and animals
  • 3Systematic investigation of mechanisms of action
  • 4No adverse events reported across all studies
⚠️

Limitations

  • 1Inconsistency in clinical efficacy across studies
  • 2Few well-designed double-blind studies
  • 3Lack of standardization in treatment protocols
  • 4Difficulty integrating TCM theory with modern research methodology
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Rheumatoid arthritis confronts the clinician with a therapeutic challenge that goes beyond pharmacologic control of inflammation: a substantial proportion of patients with moderately active disease remain symptomatic despite DMARDs and biologics, or develop intolerance to these drugs. In that setting, acupuncture emerges as an analgesic and anti-inflammatory adjunct with a notable safety profile — no adverse events across the reviewed studies. Effectiveness rates ranging from 79.2% to 95% cover relevant clinical outcomes: reductions in pain, morning stiffness, swollen-joint counts, and inflammatory markers such as ESR, CRP, and rheumatoid factor. Older populations with polypharmacy and elevated risk of NSAID toxicity, or patients with cardiovascular comorbidities that constrain the use of certain agents, are natural candidates for integrating acupuncture into the rheumatologic treatment plan.

Notable Findings

The mechanistic aspect of this review is what most deserves clinical attention. Acupuncture at ST-36 — the most-used point across the analyzed protocols — demonstrated capacity to modulate pro-inflammatory cytokines central to the pathophysiology of RA: TNF-α, IL-1, and IL-6, along with regulation of the NF-κB pathway. This is not a nonspecific relaxation effect; it is modulation of molecular targets that biologics also address, via distinct neuroimmunoendocrine pathways. Animal-model studies added data on increases in superoxide dismutase and catalase, suggesting an antioxidant component independent of the cytokine axis. Increased CSF endorphins reinforce the plausibility of a central analgesic effect. That no adverse events were recorded across 44 years of compiled publications validates the safety of the technique in trained hands and strengthens the indication in higher-risk patients.

From My Experience

In my pain and rehabilitation outpatient practice, I incorporate acupuncture into RA management mainly in two scenarios: patients in the DMARD-adjustment window, when disease is still moderately active and a bridging symptomatic control is needed, and patients with laboratory-controlled disease but disproportionate residual pain — frequently with associated central sensitization. I usually observe a patient-perceived analgesic response after four to six sessions; objective reduction of morning stiffness tends to appear during the second week of consistent treatment. My usual protocol uses ST-36 bilaterally as the anchor, combining LI-4, GB-34, and periarticular local points according to the pattern of involvement. I prefer low-frequency electroacupuncture when there is an exacerbated acute inflammatory component — the mechanistic plausibility via modulation of IL-6 and TNF-α makes that choice coherent with what this work documents. Patients with needle phobia or on full anticoagulation warrant individual evaluation before the indication.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Evidence-Based Complementary and Alternative Medicine · 2018

DOI: 10.1155/2018/8596918

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.